Suture or Mesh Repair of the Smallest Umbilical Hernias: A Nationwide Database Study.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
08 2022
Historique:
accepted: 04 03 2022
pubmed: 21 3 2022
medline: 29 6 2022
entrez: 20 3 2022
Statut: ppublish

Résumé

Mesh is recommended for umbilical hernias with defects > 1 cm to reduce recurrence. For umbilical hernias with defect width ≤ 1 cm, the literature is sparse. The aim of this nationwide cohort study was to assess outcomes after suture and mesh repair of umbilical hernias with defect width ≤ 1 cm and to evaluate outcomes after onlay mesh repair specifically. By merging data from the Danish Hernia Database and the National Patients Registry from 2007 to 2018, patients undergoing elective open repair of an umbilical hernia with defect width ≤ 1 cm were identified. Available data included details about comorbidity, surgical technique, 90-day readmission, 90-day reoperation and operation for recurrence. A total of 7849 patients were included, of whom 25.7% (2013/7849) underwent mesh repair. Reoperation for recurrence was significantly decreased after mesh repair 3.1% (95% C.I. 2.1-4.1) compared with suture repair 6.7% (95% C.I. 6.0-7.4), P < 0.001. Readmission and reoperation rates were significantly higher for mesh repair 7.9% (159/2013) and 2.6% (52/2013) than for suture repair 6.5% (381/5836) and 1.5% (89/5836), P = 0.036 and P = 0.002, respectively. Onlay mesh repairs had the lowest risk of recurrence 2.0% (95% C.I. 0.6-3.5), and readmission [7.9% (65/826)] and reoperation [3.9% (32/826)] rates within 90 days were comparable to suture repairs [6.5% (381/5836)] and [3.3% (192/5836)], P = 0.149 and P = 0.382, respectively. Even for the smallest umbilical hernias, mesh repair significantly decreased the recurrence rate. Onlay mesh repair was associated with lowest risk of recurrence without increasing early complications.

Sections du résumé

BACKGROUND
Mesh is recommended for umbilical hernias with defects > 1 cm to reduce recurrence. For umbilical hernias with defect width ≤ 1 cm, the literature is sparse. The aim of this nationwide cohort study was to assess outcomes after suture and mesh repair of umbilical hernias with defect width ≤ 1 cm and to evaluate outcomes after onlay mesh repair specifically.
METHODS
By merging data from the Danish Hernia Database and the National Patients Registry from 2007 to 2018, patients undergoing elective open repair of an umbilical hernia with defect width ≤ 1 cm were identified. Available data included details about comorbidity, surgical technique, 90-day readmission, 90-day reoperation and operation for recurrence.
RESULTS
A total of 7849 patients were included, of whom 25.7% (2013/7849) underwent mesh repair. Reoperation for recurrence was significantly decreased after mesh repair 3.1% (95% C.I. 2.1-4.1) compared with suture repair 6.7% (95% C.I. 6.0-7.4), P < 0.001. Readmission and reoperation rates were significantly higher for mesh repair 7.9% (159/2013) and 2.6% (52/2013) than for suture repair 6.5% (381/5836) and 1.5% (89/5836), P = 0.036 and P = 0.002, respectively. Onlay mesh repairs had the lowest risk of recurrence 2.0% (95% C.I. 0.6-3.5), and readmission [7.9% (65/826)] and reoperation [3.9% (32/826)] rates within 90 days were comparable to suture repairs [6.5% (381/5836)] and [3.3% (192/5836)], P = 0.149 and P = 0.382, respectively.
CONCLUSIONS
Even for the smallest umbilical hernias, mesh repair significantly decreased the recurrence rate. Onlay mesh repair was associated with lowest risk of recurrence without increasing early complications.

Identifiants

pubmed: 35306587
doi: 10.1007/s00268-022-06520-1
pii: 10.1007/s00268-022-06520-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1898-1905

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Références

Appleby PW, Martin TA, Hope WW (2018) Umbilical hernia repair: overview of approaches and review of literature. Surg clin N Am 98:561–576
doi: 10.1016/j.suc.2018.02.001
Helgstrand F, Bisgaard T (2018) Time for use of mesh repair for all umbilical hernias? Lancet 391:821–822
doi: 10.1016/S0140-6736(18)30299-X
Henriksen NA, Montgomery A, Kaufmann R et al (2020) Guidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and Americas Hernia Society. Br J Surg 107:171–190
doi: 10.1002/bjs.11489
Bisgaard T, Kaufmann R, Christoffersen MW et al (2018) Lower risk of recurrence after mesh repair versus non-mesh sutured repair in open umbilical hernia repair: a systematic review and meta-analysis of randomized controlled trials. Scand J Surg 3:187–193
Kaufmann R, Halm JA, Eker HH et al (2018) Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial. Lancet 391:860–869
doi: 10.1016/S0140-6736(18)30298-8
Holihan JL, Bondre I, Askenasy EP et al (2016) Sublay versus underlay in open ventral hernia repair. J Surg Res 202:26–32
doi: 10.1016/j.jss.2015.12.014
Shrestha BM (2020) Guidelines for treatment of umbilical and epigastric hernias from the European Hernia Society and American Hernia Society. Br J Surg 107:e215
doi: 10.1002/bjs.11577
Helgstrand F, Jorgensen LN (2016) The Danish Ventral Hernia Database–a valuable tool for quality assessment and research. Clin Epidemiol 8:719–723
doi: 10.2147/CLEP.S99501
Christoffersen MW (2015) Clinical outcomes after elective repair for small umbilical and epigastric hernias. Dan Med J 62:B5161
pubmed: 26522486
Kockerling F, Brunner W, Mayer F et al (2021) Assessment of potential influencing factors on the outcome in small (< 2 cm) umbilical hernia repair: a registry-based multivariable analysis of 31,965 patients. Hernia 25:587–603
doi: 10.1007/s10029-020-02305-4
Ponten JEH, Leenders BJM, Leclercq WKG et al (2018) Mesh versus patch repair for epigastric and umbilical hernia (MORPHEUS trial); one-year results of a randomized controlled trial. World J Surg 42:1312–1320. https://doi.org/10.1007/s00268-017-4297-8
doi: 10.1007/s00268-017-4297-8 pubmed: 29026977
Ponten JEH, Leclercq WKG, Lettinga T et al (2018) Mesh OR patch for hernia on epigastric and umbilical sites (MORPHEUS-trial): the complete two-year follow-up. Ann Surg 270:33–37
doi: 10.1097/SLA.0000000000003086
Porrero JL, Cano-Valderrama O, Castillo MJ et al (2018) Importance of mesh overlap on hernia recurrence after open umbilical hernia repair with bilayer prosthesis. Am J Surg 216:919–922
doi: 10.1016/j.amjsurg.2018.01.041
Oma E, Jensen KK, Jorgensen LN (2017) Increased risk of ventral hernia recurrence after pregnancy: a nationwide register-based study. Am J Surg 214:474–478
doi: 10.1016/j.amjsurg.2017.03.044
Henriksen NA, Bisgaard T, Helgstrand F et al (2020) Smoking and obesity are associated with increased readmission after elective repair of small primary ventral hernias: a nationwide database study. Surgery 168:527–531
doi: 10.1016/j.surg.2020.04.012
Kokotovic D, Bisgaard T, Helgstrand F (2016) Long-term recurrence and complications associated with elective incisional hernia repair. JAMA 316:1575–1582
doi: 10.1001/jama.2016.15217
Helgstrand F, Rosenberg J, Kehlet H et al (2012) Reoperation versus clinical recurrence rate after ventral hernia repair. Ann Surg 256:955–958
doi: 10.1097/SLA.0b013e318254f5b9
Henriksen NA, Jorgensen LN, Friis-Andersen H et al (2022) Open versus laparoscopic umbilical and epigastric hernia repair: nationwide data on short- and long-term outcomes. Surg Endosc 36:526–532
doi: 10.1007/s00464-021-08312-5

Auteurs

Nadia A Henriksen (NA)

Department of Gastrointestinal and Hepatic Diseases, Herlev Hospital, University of Copenhagen, Borgmester Ib Juuls Vej 1, 2730, Herlev, Denmark. nadiahenriksen@gmail.com.

Kristian Kiim Jensen (KK)

Digestive Disease Center, Bispebjerg University Hospital, Copenhagen, Denmark.

Thue Bisgaard (T)

Department of Surgery, Zealand University Hospital, Koege, Denmark.

Frederik Helgstrand (F)

Department of Surgery, Zealand University Hospital, Koege, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH